Literature DB >> 8488355

Resection for second and third primary lung cancer.

L P Faber1.   

Abstract

The continued increasing incidence of bronchogenic carcinoma increases the likelihood that a patient may develop a second or third primary tumor. We have carried out a second thoracotomy for 114 patients who met our criteria of having a new primary lung cancer. These criteria were a different histologic cell type, a tumor-free interval of 24 mo, the second primary in the contralateral lung, or the new tumor in a separate and distinct ipsilateral lobe if the tumor was on the same side. There were 18 patients who had a thoracotomy for a third primary lung cancer and they met the same criteria. There were 73 segmental resections in the 132 thoracotomies, and a conservative resection is important to minimize postoperative complications. Operative mortality for the second resection group of patients was 8.8% (10/114). There was one operative death in the 18 patients undergoing a third resection. The cumulative survival rate following a second resection in 114 patients with metachronous tumors was 33% at 5 yr and 20% at 10 yr. Early detection of a second and third primary lung cancer and surgical resection offers the greatest chance for long-term survival in this group of patients.

Entities:  

Mesh:

Year:  1993        PMID: 8488355     DOI: 10.1002/ssu.2980090212

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  5 in total

1.  Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.

Authors:  Christopher T Erb; Kevin W Su; Pamela R Soulos; Lynn T Tanoue; Cary P Gross
Journal:  Lung Cancer       Date:  2016-07-19       Impact factor: 5.705

2.  Efficacy of repeated surgery is superior to that of non-surgery for recurrent/second primary lung cancer after initial operation for primary lung cancer.

Authors:  Haitao Zhou; Xiaozheng Kang; Liang Dai; Wanpu Yan; Yongbo Yang; Yao Lin; Ke-Neng Chen
Journal:  Thorac Cancer       Date:  2018-06-19       Impact factor: 3.500

3.  Completion pneumonectomy: Indications and outcomes in non-small cell lung cancer.

Authors:  Serkan Yazgan; Ahmet Üçvet; Soner Gürsoy; Özgür Samancılar
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

4.  Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years.

Authors:  F Pasini; G Verlato; E Durante; G de Manzoni; F Valduga; S Accordini; C Pedrazzani; A Terzi; G Pelosi
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

Review 5.  [Diagnosis and Treatment for Multiple Primary Lung Cancer].

Authors:  Lijie Tan; Jun Yin
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.